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An outbreak of dengue hemorrhagic fever/
dengue shock syndrome (DHF/DSS) occurred in
Delhi, India, and its adjoining areas, from
August through November 1996. We confirmed
the etiologic agent of this outbreak as dengue
virus type 2 by virus cultivation and indirect
immunofluorescence with type-specific mono-
clonal antibodies. This is the largest culture-
confirmed outbreak of DHF/DSS in India and
indicates a serious resurgence of dengue virus
infection in this country.
Dengue fever occurs worldwide, in nearly all
tropical and subtropical countries (1). Dengue
virus was first isolated in India in 1945 (2). All
four virus types circulate and cause epidemics,
but only occasional cases of DHF/DSS have been
reported in India (3).
Delhi, situated in the northern part of
India, had outbreaks of dengue virus infection
due to different dengue virus types in 1967,
1970, 1982, and 1988, but no culture-confirmed
cases of DHF/DSS were reported during these
epidemics (4-7). Some cases of DHF were seen
for the first time in 1988 (7). These were
confirmed only serologically, by the hemagglu-
tination inhibition test.
Delhi had its largest outbreak of DHF/DSS in
1996. The outbreak started the last week of
August and continued until the end of
November, peaking in mid-October (8,9). A total
of 8,900 cases were reported, with a death rate of
4.2% (9). We report results of virologic testing of
samples received at the All India Institute of
Medical Sciences from patients with suspected
dengue fever or denguelike illness from Delhi
and its adjoining areas, along with a profile of the
culture-confirmed cases.
Virus isolation was carried out on 149
samples received on ice from patients with acute
illness. Serum was separated aseptically and
stored at -70o C. The standard method of virus
cultivation, which used the C6/36 clone of Aedes
albopictus  cell line, was followed with some
modifications (10).
On days 5 and 10, cells were tested by
indirect immunofluorescence assay (IFA) by
using monoclonal antibodies to dengue virus
types 1-4. If IFA was negative for dengue viruses
on first passage, a second passage was made, and
cells were again harvested on days 5 and 10 for
IFA. All four dengue virus types (from the
National Institute of Virology, Pune, India) were
included as positive controls, and uninfected
C6/36 cells were kept as negative controls.
Dengue viruses were isolated in C6/36 cells
from 27 (18.1%) of 149 samples processed for
virus isolation. Of the 27 isolates, 26 were
identified as dengue virus type 2 and one as
dengue virus type 1. Sixteen of the 27 isolates
were from patients with DHF/DSS, while 11
were isolated from patients with uncomplicated
dengue fever. Of the 27 culture-positive patients,
11 (40.7%) were in the 5- to 12-year age group
(Table). However, the isolates were nearly
equally distributed among children (<12 years)
and adults. The ratio of male to female in these
27 cases was 12:15. The median duration of fever
at the time of viral isolation was 4 days, on the
basis of 24 culture-positive cases for which the
duration of fever was available. After 5 days of
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Table. Age distribution of patients with culture-positive
dengue
Age (years) No. of cases
0-1   2
>1-5   1
>5-12 11
>12-20   7
>20-30   4
>30   2
fever, virus isolation was possible only from one
patient. The median duration of viremia in
dengue type 2 infection was also found to be
4 days in a detailed study on dengue viremia
from Jakarta, Indonesia (11). Testing for
immunoglobulin (Ig) M antibodies to dengue
virus was performed on 270 serum samples by
MAC-ELISA according to a standard protocol
(12). Of 270 sera tested for antibodies to dengue
virus by MAC-ELISA, 140 (51.9%) showed anti-
dengue IgM antibodies. All samples from
patients with a duration of fever ³ 5 days were
tested for anti-dengue IgM antibodies. In some
samples, antibodies could be detected as early as
the fifth day of fever. Three of the culture-
positive acute-phase samples were also positive
by MAC-ELISA.
Analysis of the outbreaks of dengue virus
infection in Delhi indicates a seasonal trend. All
outbreaks (including the one reported here)
occurred during the monsoon (rainy) season
(August to November) and subsided with the
onset of winter. Dengue virus types 1, 2, and 3
have been isolated during dengue fever
outbreaks (without DHF/DSS) in Delhi. Sero-
logic studies have also shown that dengue
infection has been endemic in this region (13).
During the 1996 outbreak of DHF/DSS, we were
able to identify dengue virus type 2 as the
etiologic agent. This is the first culture-
confirmed outbreak of DHF/DSS from Delhi and
its adjoining areas and the largest reported
outbreak of DHF/DSS from India.
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